Use of secondary optical emission as a novel biofilm targeting technology

ABSTRACT

Provided herein are methods and compositions useful for the treatment of periodontal disease exploiting optical and thermal emissions of near-infrared laser systems and fibers in order to target chromophore-stained biofilm while minimizing damage to healthy tissues.

CROSS REFERENCE TO RELATED APPLICATIONS

This application claims priority to U.S. Ser. No. 60/509,685 filed onOct. 8, 2004.

BACKGROUND

1. Field of the Invention

The present invention relates to live biofilm targeting and subsequentbacterial thermolysis for its eradication in the human body, utilizingsecondary quantum optical and thermal emissions from the distal end ofnear infrared laser delivery fibers.

2. Relevant Technologies

To date, in excess of 300 different species of bacteria have beendescribed in the human oral cavity (Moore W. E., The Bacteria ofPeriodontal Diseases, Periodontol. 2000). Most bacteria are found indental plaque and in the sub-gingival periodontal and periimplantpockets. These sub-gingival bacteria have evolved to fight and inhibitthe normal host defense system creating a unique ecological niche in theperiodontal pocket.

Subgingival bacteria find their nutrient base in the crevicular fluid ofthe periodontal pocket. Even though these bacteria are in directproximity to the highly vascularized periodontal and periimplantepithelium, they continue to grow and thrive. Despite (and arguablybecause of) the host's immune and inflammatory responses seeking toinhibit bacterial colonization and intrusion into the tissues (e.g.,mediated by lysozymes, complement formation, bradykinin, thrombin,fibrinogen, antibodies and lymphocytes), subgingival bacteria tend toprevail in the periodontal and/or periimplant pocket providing a uniqueenvironmental niche (Cimasoni, Monogr. Oral Sci. 12:III-VII, 1-152(1983)).

To successfully treat the periodontal and/or periimplant pocket andperiodontal/periimplant disease as a whole, the local inflammation andits cause must be eliminated, in an effort to re-establish an intactbarrier against the root of the tooth. A newly regenerated periodontalligament or epithelial barrier connected to the root of the tooth orimplant will limit the space available for bacterial growth. Once thecause of the immune and inflammatory responses is eliminated, theperiodontal tissues will likely heal. When dealing with implants, thedisease is even more recalcitrant and difficult to eliminate, because ofthe unique and foreign three dimensional architecture and roughenedsurface of most commercial dental implants.

Healing can be seen as new collagenous and epithelial attachments beginto form in the area just inferior to the base of the periodontal pocket.These new periodontal ligament fibers generally occur only in areas notpreviously exposed to live bacteria in the pocket. In contrast, theepithelial seal known as long junctional epithelium (i.e., a strongepithelial adaptation to the root surface) generally will occur in areasthat were exposed to the live biofilm of the periodontal pocket. Withimplants (where a periodontal ligament does not exist) new boneformation and/or long junctional epithelium are sought to reduce theavailable space for bacterial growth.

Traditional Approaches

Periodontal/periimplant instruments have been invented and designed overthe years for the specific goal of plaque and calculus removal, rootplaning and debridement, and removal of diseased periodontal/periimplanttissues. In particular, periodontal scaling, root planing and curettageinstruments are the mechanical approaches of choice to remove dentalplaque, calculus, diseased cementum, and diseased pocket soft tissues.

A number of pharmacological approaches have been developed as an adjunctto traditional mechanical approaches to attack bacteria (e.g., extendedrelease antimicrobial formulations for delivery in theperiodontal/periimplant pocket after mechanical debridement). However,these pharmacological modalities have significant limitations because tobe effective they must (a) reach the intended site of action (a deepthree-dimensional pocket), (b) remain at an adequate concentration, and(c) last for a sufficient duration of time.

To remain at an adequate concentration and last for a sufficientduration of time, the intrasulcular delivery vectors of theantimicrobials (e.g., resorbable gels, resorbable microspheres, andantimicrobial impregnated chips) must fill the physical space of theperiodontal pocket. Most of these vectors stay in place in theperiodontal pocket for the duration of the drug delivery therapy (up tothree weeks), and hence prevent the immediate healing process of newperiodontal attachment and long junctional epithelium formation at thetooth/implant pocket interface after mechanical debridement. Inaddition, the majority of local antimicrobials used are bacteriostatic,and never fully eliminate periodontal and/or periimplant pathogens fromthe treatment site. Long term resistant strains often arise in theperiodontal pocket in response to sub-lethal antimicrobial absorption.Not surprisingly, these local pharmacological modalities have beenreported to have only marginal success rates (The Role of ControlledDrug Delivery for Periodontitis, Position Paper from AAP, 2000) and tohave severe limitations ultimately leading to re-infection and continueddisease progression.

Recent Developments: the Biofilm Paradigm

The recognition that subgingival dental plaque exists as a livingbiofilm has shed some light on the underlying mechanism at work(Periodontology 2000 (supra); and Chen, J. Calif. Dent. Assoc. (2001).

Costerton et al., J. of Bacteriol. (1994), have described biofilms asmatrix enclosed bacterial populations adherent to each other and/or tosurfaces or interfaces. The same researchers have also describedbiofilms as ecological communities that have evolved to permit survivalof bacterial the community as a whole, with specialized nutrientchannels within in the biofilm matrix (a primitive circulatory system)to facilitate the movement of metabolic wastes within the colony. Ifdental plaque and sub gingival bacterial colonies are now viewed as aliving biofilm, there is a need (not only limited to dentistry) foreffective biofilm targeting techniques.

Current understanding of biofilms has conferred upon them some basicproperties (Marsh et al., Adv. Dent. Res. (1997)). These include but arenot limited to actual community cooperation between different types ofmicroorganisms, distinct and separate microcolonies within the biofilmmatrix, a protective matrix surrounding the bacterial colonies,different distinct microenvironments within different microcolonies,primitive communication systems, and unique protection from andresistance to antibiotics, antimicrobials, and the immunological andinflammatory host response.

Most previous attempts to control periodontal diseases have beenperformed based on traditional understanding of periodontal andperiimplant bacteria in in vitro. As a living biofilm (in vivo) however,subgingival plaque and periodontal bacteria act and function quitedifferently than the classical laboratory models would predict.Periodontal and periimplant bacteria in a live biofilm produce differentand more harmful chemicals and enzymes than they do in culture in thelaboratory. Also, within a biofilm, there is an increase in the spreadof antibiotic resistance through inter-species relationships.

The biofilm (a proteinaceous slimy matrix) itself serves as an effectivebarrier of protection from many classical therapeutic regimens targetingbacteria. Antibiotics may fail to even penetrate the biofilm and reachthe causative bacteria if they are neutralized by resistant enzymaticreactions within the biofilm.

This new understanding of the ethiology underlying periodontal diseasehas thus identified a void and a need for novel procedures targeting thebiofilm directly to combat periodontal disease and the recalcitrantbiofilms that harbor and protect the pathogenic bacteria. Suchtechniques are hereinafter referred to as Biofilm Targeting Technologies(BTT).

Various dyes and other compounds have been proposed for the expresspurpose of disinfecting or sterilizing tissues in the oral cavity. Ithas been proposed to selectively target bacteria for laser irradiationwith chromophores in the oral environment to expedite bacterialthermolysis. Specifically, there are proposals for treating inflammatoryperiodontal and periimplant diseases along with other lesions in theoral cavity, by: (a) contacting the tissues, wound or lesion, with aredox agent (dye) such that the bacteria themselves take up thecompound, and are inhibited over time, by the exogenous agent in theabsence of a laser; or by (b) contacting the tissues, wound or lesion,with a photosensitizing compound (dye) such that the bacteria and/ortissues themselves take up the compound, and then irradiating thetissues or lesion with laser light (generally soft visible red lasers)at the specific wavelength absorbed by the photosensitizing andtargeting chromophore.

Despite the large literature relating to the use of dyes and laserirradiation in the context of treatment of oral cavity tissues, thereremains a need for effective direct targeting and thermolysis in vivo ofthe biofilm which would minimize harm to healthy tissues and promotehealing.

In view of the foregoing, it would be an advancement in the art toprovide new approaches for use in treating periodontal and periimplantdisease that addressed the drawbacks of the approaches presentlyavailable. In particular, it would be an advancement to provideapproaches for the treatment of bacterial fueled inflammatory diseasesby effectively targeting and destroying the whole live biofilm (andconsequently the bacteria) in the three dimensionalperiodontal/periimplant space, without harming the healthy dental orother tissues. In particular it would be an advancement to provide novelmethods for treating a diseased tissue exploiting optical and thermalemissions of near-infrared diode laser systems and fibers in order totarget chromophore stained biofilm while minimizing damage to healthytissues. Furthermore, it would be a desirable advancement to identifymethods and means for targeting disease tissue with increasedspecificity as evidenced by a better control of the coagulation zone ofincision with reduced deeper effects.

SUMMARY OF THE INVENTION

The present invention provides a novel approach and compositions(including kits) to expand the therapeutic window of opportunitycurrently available with conventional dental solid state diode andNd:YAG lasers in the near infrared spectrum to coagulate live biofilmand kill bacteria thermally without harming the healthy dentalstructures and tissues of the patient.

To accomplish biofilm coagulation and bacterial thermolysis with a laser(e.g., a dental diode or Nd:YAG laser), there is a small therapeuticwindow of opportunity available to eliminate the live biofilm and oralpathogenic bacteria from periodontal and periimplant sites. This isaccomplished as the optical energy from the laser is converted to localthermal energy in the target site and tissue. Because this therapeuticwindow is so small, a method is presented to expand the range of thedental diode and Nd:YAG laser to make live biofilm coagulation andbacterial elimination through the thermal deposition of energy a saferand more predictable process. The present invention uses localizeddelivery of targeting chromophore for the live biofilm in theperiodontal or periimplant site. This allows the two parameters, of (1)energy output of the laser and (2) time of laser application, to belowered to accomplish the tasks of live biofilm coagulation andsubsequent bacterial thermolysis in a safer environment.

BRIEF DESCRIPTION OF DRAWINGS

For a fuller understanding of the nature and objects of the presentinvention, reference is made to the following specification, which is tobe taken in connection with the accompanying drawings wherein:

FIG. 1 is a graph illustrating the spectral radiant exitance of ablackbody radiator at different temperatures. On the ordinate (y axis)are shown various optical densities and on the abscissa (x axis) areshown various wavelengths.

FIG. 2 is a diagram illustrating a chromaticity map for a representativechromophore dye according to the invention: Methylene Blue.

FIG. 3A is a diagram illustrating a clean cleaved optical fiber tipbefore blackbody reaction according to the invention.

FIG. 3B is a diagram illustrating the secondary optical and thermalenergy generated from a carbonized laser delivery fiber according to theinvention.

FIG. 4. is a diagram illustrating the optical fiber now converted to anincandescent blackbody radiator (the “hot tip” of the invention) incontact with the tissue being treated (i.e., the periodontal pocket).

FIG. 5 is a diagram illustrating a syringe as an example of a deliverysystem for the delivery of Methylene Blue to the periodontal orperiimplant pocket by use of a syringe.

FIG. 6 is a photograph showing the optical fiber now converted to the“hot tip” of the invention identifiable as an incandescence.

FIG. 7 is a diagram illustrating an especially adapted optical fiber tipaccording to one of the embodiments of the invention, showing the etchedfiber wall and the distal end of the optical fiber.

DETAILED DESCRIPTION

The present invention capitalizes on the discovery that significant andfactual quantum interactions occur with the distal end of near-infraredlaser delivery optical fibers, when the tip of the optical fiber of anear-infrared diode or Nd:YAG laser comes into contact withperiodontal/periimplant tissues and instantly becomes a carbonized “hottip”. These quantum and thermodynamic realities are exploited to achievetargeted live biofilm thermolysis using near-infrared lasers and thesecondary quantum emissions from the optical fiber (delivery tips) usedaccording to the invention.

The inventor has devised inter alia novel contact “hot tip” techniquesexploiting the instantaneous transformation of the laser optical fibers(e.g., the silica fibers) in the delivery device of conventionalnear-infrared diode or Nd:YAG lasers into incandescent blackbodyradiators capable of cutting and vaporizing tissues (see FIG. 1 showingthe spectral radiance of a blackbody radiator at differenttemperatures). Such incandescent blackbody radiators have been found tohave quantum and thermodynamic properties useful for the treatment ofdiseased periodontal and/or periimplant tissues and specifically for thereduction of live biofilm.

When an unclad optical fiber tip emitting photons (FIG. 3A) to a targettissue comes in contact with a live biofilm, or other biological mattersuch as blood, it will immediately accumulate debris that “stick” to thefiber itself. This debris has been found to immediately absorb theintense near-infrared laser energy propagating through the optical fiberthereby causing an increase in temperature and carbonization of the same(hence the term “hot tip” henceforth designating the blackbodyincandescent tip and the carbonized coagulum). The temperature escalatesas the energy from the infrared laser photons continues to bombard (andbe absorbed by) the newly carbonized hot tip. Upon its conversion to ablackbody radiator (and as it becomes incandescent and it glows, seeFIG. 3B), the optical fiber generates a secondary visible opticalemission (see FIG. 6).

As used in this specification, the singular forms “a,” “an” and “the”specifically also encompass the plural forms of the terms to which theyrefer, unless the content clearly dictates otherwise. As used in thisspecification, whether in a transitional phrase or in the body of theclaim, the terms “comprise(s)” and “comprising” are to be interpreted ashaving an open-ended meaning. That is, the terms are to be interpretedsynonymously with the phrases “having at least” or “including at least”.When used in the context of a method, the term “comprising” means thatthe process includes at least the recited steps, but may includeadditional steps. When used in the context of a composition, formulationor a kit the term “comprising” means that the compound or compositionincludes at least the recited features or components, but may alsoinclude additional features or components.

The methods and compositions according to the invention thus combine theprimary emissions of conventional near-infrared diode or Nd:YAG laserswith the secondary quantum emissions from the optical laser usedaccording to the invention for the treatment of chromophore-stainedperiodontal or periimplat tissue to target live biofilm thus treatingperiodontal disease in a tissue (e.g., in the oral cavity). One of skillwill appreciate that while the invention is exemplified in the dentalfield, it may be applied in many other fields targeting infections invirtually any tissue. Hence, for example the tissue could be the hip,where irrigation with a chromophore (e.g., 1% Methylene Blue solution)and the subsequent use of a laser according to the invention willcoagulate the targeted infection in that area of the body. Furthermore,while the invention is exemplified in human patients, the methods andcompositions of the present invention are intended for use with anymammal that may experience the benefits of the method and composition ofthe invention. Foremost among such mammals are humans, although theinvention is not intended to be so limited, and is also applicable toveterinary uses. Thus, in accordance with the invention, “mammals,” or“mammal in need,” or “patient” include humans as well as non-humanmammals, particularly domesticated animals including, withoutlimitation, cats, dogs, and horses.

A large number of laser sources in the infrared spectrum have been usedto kill pathogenic bacteria in dentistry and medicine. For the last fewyears near infrared solid state diode and Nd:YAG lasers have been usedin the field of dentistry for tissue cutting, cautery, and bacterialthermolysis. The four most widely used dental near infrared wavelengthsare 810 nm, 830 nm, 980 nm and 1064 nm. These near infrared lasers havevery low absorption curve in water, and have a very deep tissuepenetration values as detailed infra.

The patents, published applications, and scientific literature referredto herein establish the knowledge of those with skill in the art and arehereby incorporated by reference in their entirety to the same extent asif each was specifically and individually indicated to be incorporatedby reference. Any conflict between any reference cited herein and thespecific teachings of this specification shall be resolved in favor ofthe latter. Likewise, any conflict between an art-understood definitionof a word or phrase and a definition of the word or phrase asspecifically taught in this specification shall be resolved in favor ofthe latter.

Technical and scientific terms used herein have the meaning commonlyunderstood by one of skill in the art to which the present inventionpertains, unless otherwise defined. Reference is made herein to variousmethodologies and materials known to those of skill in the art.

An aspect of the invention provides novel methods for the treatment ofperiodontal disease in a periodontal or periimplant tissue of a patienthaving periodontal disease. The tissue being treated by the methods ofthe invention is contracted with a heat sink moiety including at least adye absorbing at a predetermined spectral range. A “heat sink” moiety isany entity capable of receiving, absorbing, or otherwise diverting heatfrom the tissue being irradiated. Heat sink moieties according to theinvention include compounds known to act as chromophore dyes (i.e.,molecules that preferentially absorb optical energy). The term“predetermined spectral range” is from about 400 nm to about 1100 nm. Incertain embodiments, the chromophore dye has absorption bands (and thusa predetermined spectral range of) from about 600 to about 700 nm. Aheat sink moiety needs to be essentially non-toxic to tissues, needs tobe able to penetrate live biofilm, and—most important—needs to beselectively absorbed by the live biofilm to target the same withoutdamaging the patient tissues. Representative non-limiting examples ofchromophore dyes include Toludine Blue (with absorption spectra between600 to 700 nm), Methylene Blue (MB, with absorption peaks at 609(orange) and 668 nm (red)), Congo Red (with strong absorption band at340 nm in the near-ultraviolet region and another at 500 nm near theblue-green transition region), and Malachite Green (with a strongabsorption band centered at 600 nm near the yellow-red transitionregion, and any other tissue safe biological dye). One of skill willappreciate that chromophore dyes may be administered in a compositionform including any known pharmacologically acceptable vehicle with anyof the well known pharmaceutically acceptable carriers, includingdiluents and excipients (see Remington's Pharmaceutical Sciences,18^(th) Ed., Gennaro, Mack Publishing Co., Easton, Pa. 1990 andRemington: The Science and Practice of Pharmacy, Lippincott, Williams &Wilkins, 1995).

The term “about” is used herein to mean approximately, in the region of,roughly, or around. When the term “about” is used in conjunction with anumerical range, it modifies that range by extending the boundariesabove and below the numerical values set forth. In general, the term“about” is used herein to modify a numerical value above and below thestated value by a variance of 20%.

According to the methods of the invention, the periodontal/periimplanttissue stained with the chromophore dye (composition) is irradiated withoptical energy in the near infrared spectral range.

The skilled practitioner will realize that the instant inventioncombining live biofilm chromophore targeting and thermolysis, may beused to augment traditional approaches by promoting healing upon removalof the live biofilm. Accordingly, the methods and compositions of theinvention could be used to target the live biofilm in the periodontal orperiimplant pocket (see FIG. 4) followed by mechanical debridement ofthe denatured biofilm (now reduced to a denatured and inactive solidcoagulum entrapping live and dead bacteria within their matrix in theperiodontal or periimplant pocket) and its constituent flora. By thisapproach, the periodontal/periimplant instruments (e.g., periodontalscalers or ultrasonic scalers) are able to scale and debride thedenatured biofilm out of the local area with much greater success thanwould be possible if the slimy live biofilm remained uncoagulated. Livebiofilm chromophore targeting thus, achieves the goals of traditionalbacterial removal by traditional scaling and mechanical debridement.Moreover, it seeks out and target previously inaccessible areas forperiodontal/periimplant pocket treatment and concurrently kills andremoves the living biofilm as a denatured inactive solid coagulum.

Similarly, the instant methods and compositions may be combined withtraditional approaches involving antibacterial modalities found in theliterature such as for example antibiotic treatment (for a standardreference works setting forth the general principles of pharmacologysee, Goodman and Gilman's The Pharmacological Basis of Therapeutics,10^(th) Ed., McGraw Hill Companies Inc., New York (2001); for a generalreference relating to the use of antibiotics in dentistry see forexample, Rose et al., Periodontics: Medicine, Surgery, and Implants,June 2004 in concomitance with or following laser treatment. Hence, asexemplified hereinafter (see Example 2) a patient may be treated with apenicillin to prevent reinfection. Such combinations may be effectedprior to, in conjunction with, and/or following laser treatment(irradiation). Hence, formulations of compositions according to theinvention may contain more than one type of chromophore dye according tothe invention, as well any other pharmacologically active ingredientuseful for the treatment of the symptom/condition being treated. Hence,in some instances the practitioner may opt to co-administer other activeor inactive components including, but not limited to, antibiotics,analgesics, and anesthetics. Examples of useful antibiotic orantimicrobial agents include, but are not limited to, chlorhexidinegluconate, triclosan, cetyl pyridinium chloride, cetyl pyridiniumbromide, benzalkonium chloride, tetracycline, methyl benzoate, andpropyl benzoate. Examples of useful anesthetic agents include, but arenot limited to, benzocaine, lidocaine, tetracaine, butacaine, dyclonine,pramoxine, dibucaine, cocaine, and hydrochlorides of the foregoing.

As used herein, by “treating” is meant reducing, preventing, and/orreversing the symptoms in the patient being treated according to theinvention, as compared to the symptoms of an individual not beingtreated according to the invention. A practitioner will appreciate thatthe compounds, compositions, and methods described herein are to be usedin concomitance with continuous clinical evaluations by a skilledpractitioner (physician or veterinarian) to determine subsequenttherapy. Hence, following treatment the practitioners will evaluate anyimprovement in the treatment of the disease according to standardmethodologies. Such evaluation will aid and inform in evaluating whetherto increase, reduce or continue a particular treatment dose, mode ofadministration, etc.

Live biofilm targeting and secondary emission coagulation of the biofilmcan be accomplished without harming collateral tissues, healthyperiodontal/periimplant architecture or the tooth. Further, this can beaccomplished without (necessarily) introducing antibiotics or resorbabledelivery vectors into the system or periodontal pocket, and will allowfor the immediate healing and reattachment of periodontal tissues tobegin.

The bacteria targeted in accordance with the present invention are thosespecifically involved in art-known periodontal and periimplantinfections (e.g., Actinobacillis actinomycetemcomitans, Porphyromonasgingivalis, Prevotella intermedia/nigrescens, Bacteroides forsythus,Fusobacterium species, Peptostreptococcus micros, Eubacterium species,Camplobacter rectus, streptococci, and Candida species). Alsocontemplated are art-known periimplant infectious bacteria (e.g.,Fusobacterium spp., Prevotella intermedia, Porphyromonas gingivalis,Actinobacillus actinomycetemcomitans, Peptostreptoccus micros,Bacteroides spp., Capnocytophaga spp., Prevotella spp., Spriochetes,Staphylococcus spp., Enteric gram-negative bacteria, Campylobactergracilis, Streptoccus intermedius, Streptococcuc constellatus, Candidaalbicans, and Eikenella corrodens).

The energy may be provided by any suitable source of coherent energy,e.g., a laser, capable of emitting optical energy having a wavelengthfrom about 500 to about 1500 nm, if necessary or convenient usingoptical fibers or other known optical devices to deliver the energy tothe periodontal and/or the periimplant being treated. In certainembodiments, the optical energy generated is coherent energy (e.g.,generated by a laser such as a diode laser or a Nd:YAG laser operatingat 350-1200 mW, preferably at 500-1200 mW, or at 800-1200 mW). Thus,lasers according to the invention include those emitting optical energyhaving a wavelength of from about 500 to about 1500 nm, preferably fromabout 600 to 1100 nm, or from about 800 to about 1100 nm. Inrepresentative non-limiting examples shown herein the wavelength is fromabout 800 to about 1064 nm.

There are generally five factors to consider regarding heat generationby the primary emissions of near infrared lasers when the distal end ofthe laser fiber is clean and well cleaved (as a general reference, seeNiemz M, Laser-Tissue Interactions. Fundamentals and Applications,Berlin, Springer, pp 45-80, 2002)). These factors are: (1) wavelengthand optical penetration depth of the laser; (2) absorptioncharacteristics of exposed tissue; (3) temporal mode (pulsed orcontinuous); (4) exposure time; and (5) power density of the laser beam.

Diode lasers in the near infrared range have a very low absorptioncoefficient in water, hence they achieve deep optical penetration intissues that contain 80% water (including the oral mucosa, bone andgingiva). This means that for a conventional dental diode soft tissuelaser the depth of penetration per pulse is estimated by Niemz to beabout 4 cm. The shorter wavelengths of the near-infrared diode andNd:YAG lasers have very high absorption peaks in molecules(chromophores) such as melanin and hemoglobin. This will allow the laserenergy to pass with minimal absorption through water, producing thermaleffects much deeper in the tissue (as photons are absorbed by the deepertissue pigments). This photobiology allows for controlled deepersoft-tissue coagulation, as the photons that emerge (in a cone patternof energy) from the distal end of a clean cleaved near-infrared diodelaser fiber, are absorbed by blood and other tissue pigments.

The next parameter to bear in mind is the heat effect on the tissuebeing irradiated, based on the pulse mode of currently availablenear-infrared systems. Presently, for periodontal treatment,near-infrared lasers either emit photons in the Continuous Wave (CW) orGated CW Pulsed Mode for Diode systems, and Free Running Pulsed (FRP)for Nd:YAG's. Thus, because the length (duration) of the tissue exposureto the photon energy of the laser will govern the thermal tissueinteraction that is achieved.

In the CW or Gated CW mode, laser photons are emitted at one singlepower level, in a continuous stream. When the stream is Gated, there isan intermittent shuttering of the beam, as a mechanical gate ispositioned in the path of the beam, essentially turning the laser energyon and off. The duration of on and off times, of this type of lasersystem is generally on the order of milliseconds (1 millisecond=1/1000th of a second), and the “power-per-pulse” stays at the averagepower of the CW beam. Nd:YAG lasers (in the FRP mode) can produce verylarge peak energies of laser energy, for extremely short time intervalson the order of microseconds (1 microsecond= 1/1,000,000th sec). As anexample, one of these lasers with a temporal pulse duration of 100microseconds, with pulses delivered at ten per second (10 Hz), wouldmean that the laser photons are hitting the tissue for only 1/1000th ofa second (total time) and the laser is “off” for the remainder of thatsecond. This will give the tissue significant time to cool before thenext pulse of laser energy is emitted. These longer intervals betweenpulses will benefit the thermal relaxation time of the tissue. The CWmode of operation will always generate more heat than a pulsed energyapplication.

If the temporal pulses are too long (or the exposure in CW is too long),the thermal relaxation effect in the tissues is overcome andirreversible damage to non-target areas can occur. An added safetyfeature is provided by the Methylene Blue acting as a “heat sink” aroundvital tissues providing a larger margin of error cooling and appropriateexposure times are miscalculated. So, not only the ultimate temperaturereached in the tissue interaction with the laser energy is of concern,but also the temporal duration of this temperature increase plays asignificant role for the induction of desired tissued effects, and theinhibition of irreversable tissue damage. For nano- and pico-secondpulses, heat diffusion during the laser pulse would be negligible,however presently available dental lasers cannot achieve such pulses.

The power density of the beam is determined by the peak power generatedby the laser, divided by the area of the focused beam. This means thatthe smaller the diameter of the fiber used to deliver the energy (200μm, 400 μm, 600 μm), and the closer the fiber is to the tissue (i.e., asmaller “spot size”, not touching the tissue), the greater the powerdensity (amount of emitted photons per square mm of the beam) and thegreater the thermal interaction. With a non-contact “clean” fiber tip,the two most important considerations are the spot size of the beam, andthe distance of the fiber tip to the tissue.

There is an immediate and profound change in the quantum emissions ofthe laser fiber, and an immediate and profound change in the tissueresponse and photobiology when an unclad “naked” fiber tip comes incontact with periodontal and/or periimplant tissue at any fluence aboveabout 300 mW continuous output. This occurs in 100% of all intrasulcularperiodontal procedures using simple naked unclad fibers, regardless ofthe diode laser or Nd:YAG wavelength from approximately 600 nm to 1100nm. When an unclad “naked” fiber tip comes in contact with periodontaltissue and intrasulcular fluids, cellular debris and biofilm willimmediately accumulate on the unclad tip, and this debris will instantlyabsorb the intense infrared laser energy propagating through the fiber,which will cause the tip to heat and immediately carbonize. As theenergy from the infrared laser photons continues to be absorbed by thisnewly carbonized tip, (within as short a time as a single second) thetip will become red hot (above 726° C.). This resulting secondaryquantum emission of the “hot tip” energy to the tissue is associatedwith different heat transfer and photobiologic events in the periodontalpocket and periodontal tissues. That is the primary focus of thisinvention. This allows the two parameters, of (1) energy output of thelaser and (2) time of laser application, to be lowered to accomplish thetasks of live biofilm coagulation and subsequent bacterial thermolysisin a safer environment.

By direct live biofilm chromophore targeting, and for the first timeexploiting the inherent secondary quantum emissions with this hot tiptechnique and the chromophore Methylene Blue, the operator of an 800nm-1064 nm dental laser can decrease the power of the laser toapproximately 0.05-1.5 Watts, and decrease the time needed in the areaof treatment. Even with turning down the energies, and treating the areaof the periodontal or periimplant pocket for less time than would benecessary without the chromophore heat sink, live biofilm phase changethrough coagulation and thermolysis of the bacteria within the biofilmwill occur. This will lead to a safer procedure for the patient, andpreserve more collagen, bone, and mucosa in the periodontal/periimplantpocket from irreversible thermal damage during the procedure.

With the “hot tip” technique the deeply penetrating primary laser energyis substantially reduced, and the photobiology and laser-tissueinteraction is different from what is found when using a non-carbonizedfiber that emits only the primary emission, near-infrared photons. Toaccomplish safe and predictable periodontal/periimplant procedures witha “hot tip”, the clinician must be mindful of the very narrowtherapeutic window afforded by the tip's thermal interactions with thetissue. When radiant optical and thermal energy is applied to biologicaltissues with a “hot tip”, the temperature of the contact area risesimmediately. At 45° C., the tissue becomes hyperthermic. At 50° C.,there is reduction in cellular enzyme activity and some cell immobility.At 60° C., proteins denature, and there is evidence of coagulation. At80° C., cell membranes become permeable, and at 100° C., water andtissue begin to vaporize.

If the temperature increases for 2 to 5 seconds beyond 80° C., therewill be irreversible damage to the mucosa, bone, periodontal, and dentalstructures. These considerations are of direct importance for contacttip procedures such as a gingivectomy, gingivoplasty, frenectomy,incision and drainage, removal of a fibroma, and periodontal sulcularcurrettage (see Rossman, J. Periodontol. 73:1231-1239 (2002)).

According to the invention, the optical fiber emitting optical energy inthe near infrared spectral range is contacted with at least a portion ofthe tissue previously stained with the chromophore dye. According to theinvention, the tissue should be irradiated for a therapeuticallyeffective amount of time in a moving pattern. The expression“therapeutically effective amount of time” and “therapeuticallyeffective time window” is used to denote treatments for periods of timeeffective to achieve the therapeutic result sought. Because of theimmediacy of the result sought (i.e., the formation of the coagulum fromthe biofilm) the practitioner is able to tailor and ascertaintherapeutically effective times visually. The invention thereforeprovides a method to tailor the administration/treatment to theparticular exigencies specific to a given patient. As illustrated in thefollowing examples, therapeutically effective amounts may be easilydetermined for example empirically by starting with a relative shorttime period and by step-wise increments with concurrent evaluation ofbeneficial effects.

Prior to the invention, the objective when using a laser with a “hottip” in the periodontal pocket, was to generate sufficient thermalenergy at the tip to cause immediate tissue vaporization and ablationlimited to the inflamed epithelial periodontal lining, otherwise knownas sulcular curettage. To accomplish it, the tissue must be rapidlyheated to several hundred degrees Celsius at the contact point of thetip. A diode or Nd:YAG laser can readily accomplish this when used inthe contact mode. As the optical and thermal energy (of the secondaryblackbody emission) is directly transferred to the tissue in thevicinity of the tip, a poorly controlled vaporization of sulcularepithelium ensues.

During these procedures, it is imperative to keep treatment contactintervals in any one spot relatively short (1 second), since any extraexposure of periodontal tissues (including tooth and bone) the tip willdamage these peripheral tissues. The will occur because the heat will betransferred deeper into the tissues via heat conduction, and will not berapidly dissipated by the tissues if there are any prolonged periods ofcontact. If the contact exposure time is too long (more than 2-3 secondsin one area), the ability of the tissues to dissipate heat is overcome,and irreversible damage occurs to non-target tissues.

As stated, in the contact mode a large percentage of the near-infraredphotons (the primary emission of the laser) are absorbed by theblackbody tip and carbonized coagulum. As a result, the emission, andhence penetration and absorption of these primary (single wavelength)infrared photons generated from the laser, are greatly decreased.Therefore, the danger to peripheral tissues (around the periodontalpocket) is directly dependent on the exposure time of the “hot tip” tothe tissue and the heat conduction from the tip to the tissue. Thesegreatly decreased primary emissions of the laser through a carbonizedtip were studied in detail by Grant et al., Lasers in Surgery andMedicine 21:65-71 (1997), as they specifically looked at the “fiberinteraction” during contact laser surgery. Grant showed that with tissuedeposits at the tip of the fiber absorbing larger amounts of laserlight, immediate carbonization occurs. The carbonization of the fibertip leads to an increase in temperature, and this can result insignificant damage to the optical quality of the fiber (the temperaturespikes to greater than 900° C.). Grant also found that once thecarbonization of the tip occurs, the tip no longer functions as anadequate forward light guide (i.e., there is now limited primary photonforward progression of laser energy). The laser will no longeradequately photocoagulate, but rather it incises and cauterizes thetissue because of the intense heat at the tip. While the hot tipdescribed in Grant et al. has direct and unimpeded energy effecting thetissues within the sulcus, the current invention's hot tip is exploitedby making it possible to coagulate the target biofilm in total (becauseof the heat sink/chromophore), while at the same time the peripheraltissues are left protected.

It is also important to remember that the silica portion of a typicaloptical fiber consists of two regions—the core that runs through thecenter of the strand, and the cladding that surrounds the core. Thecladding has a different refractive index than the core, and acts as amirror that causes the laser light to reflect back into the core duringits transmission through the fiber. Furthermore, longer lasing times andhigher power drastically reduce the forward power transmission of thelaser light, as the fiber tip sustains more and more heat induceddamage. When a 360 micron fiber (with a 830 nm diode laser at 3 wattsCW, with a laser power meter) was tested, it was found that an immediate30% loss of forward power transmission is observed with fibercarbonization from tissue detritus. Further power loss was observed aslasing time continued and tissue debris accumulated.

Willems et al., Lasers in Surgery and Medicine 28(4):324-329 (2001)elucidated this phenomenon in vivo using diode and Nd:YAG lasers.Conventional fiber tips and coated fiber tips were compared for ablationefficiency in rabbit cerebral tissue. With the conventional fiber tips,histology and thermal imaging demonstrated deleterious effects deep intothe tissue. When using the coated fiber tip, they reported that almostall laser light was transformed into thermal energy (as the tipcarbonized), and instantly produced ablative temperatures at the tipitself. Further, they reported that ablation was observed at relativelylow energy and power (1 W for 1 second) with thermal effects restrictedonly to the superficial structures. This restriction of thermal effectsto superficial structures can be explained, as the forward powertransmission of the laser light is attenuated when a larger percentageof the primary emissions of the laser are absorbed by the tip. As aresult, the optical transmission qualities are damaged. In order toprotect deeper tissues, they altered the distal end of the tip tocompletely inhibit any forward progression of primary infrared photons,whereas the present invention utilizes a chromophore/heat sink to bothtarget the biofilm and protect the surrounding tissues. Also ofsignificance, as the quality of the fiber transmission diminishes as aresult of damage to the tip, the energy, focus, and homogeneity of theenergy being transmitted from the tip is affected. The primary energythat is still available for forward power transmission out of the tip isfar less efficient for tissue penetration and photocoagulation. Thisinventor has developed a novel system to exploit these quantumrealities, with biofilm targeting technology.

Furthermore, (Proebstle et al., Dermatol. Surg. 28:596-600 (2002)) in astudy evaluating the thermal damage to the interior walls of veins with600 μm fibers in endovenous laser treatment, found no major differencescould be detected between the three diode laser wavelengths of 810 nm,940 nm, and 980 nm. The laser wavelength interaction with the bloodimmediately transferred the optical energy completely into heat at allwavelengths, even with new, uncarbonized fibers. In essence, whatProebstle's data confirms, is that when delivery tip carbonizationoccurs (now understood to be a universal event with these lasers), andtip preferentially absorbed the laser energy causing extremely hightemperature generation and a “hot tip” (all intra-pocket periodontal andperiimplant procedures) any subtle wavelength differences in the nearinfrared 800-1100 nm are not critical to the procedure being performed.

It is now understood that optical fiber tips used with near infraredlasers (600 nm-1100 nm) at moderate fluences (about 350 mw and above)experience heat induced carbonization almost immediately upon contactwith oral tissues and/or blood. The carbonization is thermally driven,and causes degradation of the forward power transmission potential fromthe tip, as the tip absorbs the primary infrared photons from the laserand becomes red hot and incandescent. Upon carbonization, this tip canbe referred to as a blackbody emitter of secondary radiation(ultraviolet, visible, and infrared light), and has a thermalinteraction and photobiology distinctly different from what occurs withclean, uncarbonized non-contact fibers. It is no longer single primaryemitter of monochromatic laser energy.

With all visible and infrared light, after the energy of the photons isabsorbed by a chrompohore, it is converted to kinetic energy within thetarget molecules (i.e., heat). The energy transferred may cause damage(e.g., excessive dosimetry). It has been found that a heat sink isideally suited in conjunction with near infrared laser periodontaltreatment with secondary quantum emissions generated from a “hot tip”blackbody radiator. Heat deposition may be due to local conversion ofoptical energy from the laser in the tissue to heat energy, or to heatconduction from the hot-tip (quantum secondary blackbody emissions) ofthe naked or unclad optical silicate delivery fiber within theperiodontal or periimplant pocket.

With these thermodynamic realities now understood, it is easilyexplained that excess power output from the laser, or excess time in adental surgical procedure can induce heat related deleterious effects tothe patient and irradiated tissues.

To accomplish safe and predictable periodontal therapy (and biofilmcoagulation with bacterial cell death) with near infrared dental diodelasers, the operator must be cognizant of the very narrow therapeuticwindow afforded by the lasers thermal interactions with human tissues.

To achieve photothermolysis (heat induced death) and live biofilmcoagulation with the near infrared dental laser, a significanttemperature increase must occur for a given amount of time in the targettissue or tissue area of the periodontal pocket. From 60° C. to 80° C.is the range of temperature in the surrounding tissue that must beachieved for short periods of time, under skilled control and delivery,for the live biofilm phase shift to occur, and transform from a slimyproteinacious matrix to a solid coagulum. This must occur for the nearinfrared dental laser to be effective at biofilm thermolysis withoutcausing undue harm to healthy oral tissues.

As the tip begins to glow (i.e., as it becomes a “hot tip”), it emitsfirst red, and then orange visible light as is evidenced by a C.I.E.Chromaticity Map that is overlaid with a blackbody locus (FIG. 2) (inthe 600 nm to 700 nm range). This emission falls exactly within theabsorption band for Methylene Blue. Thus the biofilm stained therewithselectively absorb the energy emitted by the hot tip.

The invention provides a kit for treating an in vivo biofilm and tissueon a periodontal or periimplant surface including an optical fiberextending between a proximal end and a distal end. According to theinvention, the proximal end receives optical energy incident thereon ina near infrared spectral range, and the optical fiber transmits thereceived optical energy to the distal end emitting optical energy in thepredetermined spectral range. The terms and specific features of theelements in the kits of the invention are as described above inconnection with the methods of the invention. In certain embodiments,the predetermined spectral range is from about 600 to about 700 nm.

The distal end of the optical fiber may be made of silica, zircon glassor other compatible material capable of generating a “hot tip” (e.g.,fused silica). For each different procedure and patient, the oldblackbody tip is cleaved off and the fiber sterilized to prepare thefiber for a new patient.

Kits according to the invention further include a reservoir to store achromophore dye having an absorption spectrum in the spectral range of ablackbody radiator described herein the invention. In certainembodiments, the reservoir includes an applicator assembly for theselective application of the chromophore dye to the biofilm and tissueon the periodontal or periimplant surface (such as for example a smallfiber brush, or a syringe, see FIG. 5 exemplifying a syringe and areservoir containing a 0.1% MB solution).

Kits according to the invention may further comprise an optical energysource for generating optical energy in the near infrared spectrum, andan associated coupling assembly for coupling the optical energy to theproximal end of an optical fiber. In certain embodiments, the opticalenergy generated is coherent. In other embodiments, the optical energysource is a diode laser operating at 350-1200 mW generating energyhaving a wavelength of about 830 nm.

The kits according to this aspect of the invention may also include heatsink moieties as discussed infra. Accordingly, some kits include achromophore dye such as MB. The heat sink moieities of the invention maybe provided in a reservoir adapted to store a chromophore dyecharacterized by an absorption spectrum in the spectral range of ablackbody radiator described herein the invention. The reservoir mayfurther include an applicator assembly adapted to effect selectiveapplication of the chromophore dye to a region of the biofilm on aperiodontal or periimplant surface. The chromophore dye may bepre-packed in a reservoir with a light foil cover. In some embodiments,the practitioner pushes on the brush, breaks the foil, and wets thebristles with the dye (e.g., MB) for topical deposition to the area ofthe oral cavity to be treated. These areas include the periodontalpocket, the periimplant site, and or any other site in the oral cavityrequiring treatment according to the invention.

The laser energy may be delivered through a commercially availablesurgical fiber from 200 microns to 1000 microns in diameter with anunclad and cleaved distal end, in contact or non-contact mode (FIG. 3A).The laser energy is delivered from a solid state continuous wave orpulsed dental diode or Nd:YAG laser ranging from 800 nm to 1064 nm tomake use of the secondary emission blackbody reaction with the hot tipand the absorption peak in MB. The laser energy is delivered from 1 to120 seconds per area in a moving pattern that never stays stationary formore than 2-3 seconds. The energy production from the laser at thedistal end of the conical tip fiber is no less than 200 mW and no morethan 4000 mW.

When a lasers output powers (W) and beam area (cm²) are known with aclean cleaved fiber, the remaining parameters of effective treatment canbe calculated to allow the precise dosage measurement and delivery ofenergy for effective and safe treatment to oral tissues. In theperiodontal pocket however, with the fiber tip immediately becoming anincandescent blackbody radiator, the normal power equations will notreflect the reality of the new quantum mechanics. Even with thegeneration of secondary blackbody emissions, the output power of a laserdoes not change, and simply refers to the number of photons emitted atthe given wavelength of the laser.

Before the fiber touches tissue, the power density of the laser willmeasures the potential thermal effect of laser photons at a treatmentirradiation area. Power Density is a function of Laser Output Power andBeam area (again with a clean cleaved fiber), and is calculated with thefollowing equations:

$\begin{matrix}{{{Power}\mspace{14mu} {Density}} = {\left( {W/{cm}^{2}} \right) = \frac{{Laser}\mspace{14mu} {Output}\mspace{14mu} {Power}}{{Beam}\mspace{14mu} {Diameter}\mspace{14mu} ({cm})^{2}}}} & (1)\end{matrix}$

Hence, the total photonic energy delivered into the oral tissues by adental near-infrared laser (before the clean tip touches the tissues) ismeasured in Joules, and is calculated as follows:

Total Energy(Joules)=Laser Output Power(W)×Time(Secs)  (2)

Once the tip touches biofilm or tissue and becomes an incandescentblackbody radiator, approximately 70+% of the output power of the laseris converted to local heat, it no longer emits significant monochromaticlight (i.e., because the carbonized tip is absorbing it) and it nowproduces light in a continuous distribution of wavelengths (continuousspectrum) and in all directions. Hence, there is no “spot size”available for a “power density” equation. For this reason, the totalenergy equation (2), will be used.

In some applications, it may be desirable to broaden or increase theeffective surface area from which incandescent light (that falls withinthe absorption band of the dyed biofilm) is emitted, for example bycausing incandescent radiation to be emitted from areas of the opticalfiber other than the narrow distal tip alone. In this way, an increasedamount of incandescent light may be available to be absorbed by thestained biofilm, at a faster speed, thereby more effectivelyaccomplishing the desired thermolysis of the dyed biofilm in the tissuetreated.

In some embodiments, such an increase in the effective surface area fromwhich incandescent light is emitted is accomplished by causing at leastsome light propagating from the distal tip (toward the proximal end) tobe directed onto the dyed biofilm or other target tissue, through thelateral walls of the optical fiber. As explained above, not all of theincandescent radiation (or “secondary quantum emission”) that isgenerated from the carbonized fiber optic tip is transmitted onto thetarget tissue (e.g. the biofilm stained with Methylene Blue). Rather,some of the incandescent radiation generated from the glowing carbonizedtip of the fiber propagates in “reverse” through the fiber optic core,from the distal end toward the proximal end of the optical fiber. Insome embodiments, this back-propagating incandescent radiation can bedirected onto target tissue, as described below.

In the embodiment illustrated in FIG. 7, the effective surface area fromwhich incandescent light is emitted is increased, by modifying thesurface geometry of the distal end of the optical fiber in such a waythat at least some of the back-propagating incandescent radiation can bediverted and re-directed toward target tissue by transmission throughthe lateral walls of the optical fiber. Specifically, the surfacegeometry of the lateral walls of at least a portion of the distal end ofthe optical fiber is modified, for example by etching, roughening,frosting, or other methods well known in the art, so that at least someof the back-propagating radiation no longer undergoes total internalreflection at the boundary between the core 30 and the cladding 35 ofthe optical fiber, but rather is transmitted through the lateral wallsand towards off-axis target tissue. When such transmitted light hassufficient energy density, then the sidewalls become carbonized, as didthe distal tip. Again, at sufficient energy density, the carbonizedlateral surfaces generate incandescent radiation, which interacts withthe dyed biofilm to effect thermolysis of the biofilm.

FIG. 7 illustrates an exaggerated saw-tooth geometry of a surface of thelateral walls of a portion of the distal end of the optical fiber,modified in the manner described above. FIG. 7 is not drawn to scale,and is meant to provide an exemplary schematic rendition of the etchedor otherwise modified surface geometry of the optical fiber lateralwalls, which is illustrative of the principles explained above.

As well known, optical fibers are configured so as to guide light fromone end of the optical fiber to the other end, by causing the light toundergo total internal reflection at the boundary between the core andthe cladding of the optical fiber, so that light is guided through theoptical fiber core, from one end of the fiber to the other. Thedifferences between the indices of refraction of the optical fiber coreand the optical fiber are such that, for a smooth unmodified surfacegeometry of the (typically cylindrical) optical fiber, the lighttraveling through the core is reflected off the cladding glass and stayswithin the core, so that the fiber core acts as a waveguide for thetransmitted light.

As seen in FIG. 7, in one embodiment the smooth surface of the lateralwalls of a portion of the distal end is modified or etched in such a waythat the surface is no longer smooth, but jagged or serrated. Inparticular, the etching or serrating of the surface of the optical fiberwalls is performed in such a way that the angle of incidence, at whichthe back-propagating light is incident upon the boundary, is no longergreater than the critical angle, thereby preventing the back-scatteringlight from undergoing total internal reflection. In this way,back-propagating incandescent light which, in the absence of themodification or etching of the fiber optic wall surface, would havebounced off the cladding and would have stayed within the core toreverse-propagate towards the proximal end of the optical fiber, nolonger undergoes total internal reflection at the core-claddingboundary. Rather, the back-propagating radiation incident upon thecore-cladding boundary is refracted, so that at least a portion of theback-scattered radiation incident upon the boundary is transmittedthrough the cladding glass forming the optical fiber wall, and isdirected onto the dyed film.

EXAMPLES

The laser used to exemplify the invention was a 830 nm diode laser witha power output of between 800 mW-1200 mW in the Continuous Wave mode ofoperation, through a 600 micron silica laser delivery fiber. The livehuman patients (in vivo) all presented with some advanced state ofperiodontal or periimplant disease and/or active infection. Presentedbelow are data for two representative patients. Notably, the procedurehas been performed on 50 patients in the last 24 months. In this timeperiod both the chromophore Methylene Blue and Toludine Blue have beenused with successful outcomes, specifically using this invention at thegiven parameters, in periodontal and periimplant pockets and infections.

The following examples are intended to further illustrate certainpreferred embodiments of the invention and are not limiting in nature.Those skilled in the art will recognize, or be able to ascertain, usingno more than routine experimentation, numerous equivalents to thespecific substances and procedures described herein. Reference is madehereinafter in detail to specific embodiments of the invention. Whilethe invention will be described in conjunction with these specificembodiments, it will be understood that it is not intended to limit theinvention to such specific embodiments. On the contrary, it is intendedto cover alternatives, modifications, and equivalents as may be includedwithin the spirit and scope of the invention as defined by the appendedclaims. In the instant description, numerous specific details are setforth in order to provide a thorough understanding of the presentinvention. The present invention may be practiced without some or all ofthese specific details. In other instances, well known processoperations have not been described in detail, in order not tounnecessarily obscure the present invention.

Example 1 Treatment of a Recalcitrant 10 Mm Periodontal Pocket

Presented as a healthy 24 year old with a recalcitrant 10 mm periodontalpocket on the facial aspect of the maxillary canine (tooth #6) after aregular dental cleaning and scaling. In a minimally invasive procedure,the patient was anesthetized with xylocaine, and the periodontal pocketwas infused with 0.1% MB solution via a small bristled brush that easilyfits into the volume of the pocket. The MB solution was left forapproximately 2 minutes in the area, and then surface irrigation of H₂Owas applied.

A 600 nm silica fiber connected to a 830 nm dental diode laser (sold byLumenis Technologies, Yokneam, Israel) was then activated at 1000 mW andthe fiber was placed into the periodontal pocket, where it immediatelycame in contact with biofilm, tissue, and blood products. The tip of thefiber immediately carbonized, and became incandescent. The fiber (withthe secondary quantum emissions emanating from the carbonized tip), wasthen moved around the three dimensional area of the periodontal pocketfor a period of 30 to 45 seconds in rapid movements, never staying inone direct area for more than 1 second at a time. The area was thenscaled with traditional gracey periodontal scalers (sold by Hu-FriedyChicago, Ill.), and then irrigated with copious water. The patient wassent home with administration of 600 mg of Ibuprophen (sold by Wyeth,Madison, N.J.) analgesic given chair-side, and no antibiotics.

Results: At eight days post-op, the periodontal pocket was completelyclosed, with tissue attachment present that would “blanch” underpressure from a periodontal probe. The area presented with pink andhealthy gingival surrounding the previous pocket area. At six weeks, andthen four months, the area was only probing at 3 mm (gingival andperiodontal health) and the patient was placed on regular six monthrecall.

Example 2 Treatment of Infected Periimplant Tissue

Presented as a brittle diabetic with an infected titanium implant and afistula draining the infection. Radiographic appearance detailed 8 mm oflost bone, and generalized radiolucency around the medial half of theimplant. Three different antibiotic regimens failed to cure the patientof the infection. The area was surgically opened with a conventionaltrapezoidal shaped flap, and the infection and biofilm effected area wasbathed in a 0.1% MB solution (sold by Vista Dental Products, Racine,Wis.) for approximately 2 minutes. The area was then irrigated withcopious H₂O, leaving the targeted biofilm behind, and washing awayexcess stain. A 600 nm silica fiber connected to an 830 nm dental diodelaser was then activated at 1200 mW and the fiber was placed in contactwith biofilm and blood products and immediately carbonized. The fiber,with the secondary quantum emissions emanating from the carbonized tipwere then moved around the near proximity to the area and implant(within ½ mm) for a period of 60 to 90 seconds, never staying in onedirect area for more than 2 seconds at a time. The area was then scaledwith plastic implant scalers, and irrigated with copious water andsutured closed. The patient was given a 5 day regimen of 500 mgAmoxicillin, (sold by Ranbaxy Pharmaceuticals, Jacksonville, Fla.) threetimes/day.

Result: At three weeks post-op, the area was completely free ofinfection with pink and healthy gingival surrounding the area. At fourmonths, a fixed porcelain to gold bridge was cemented onto the implant.At 9 months, the area was still infection free.

1. A kit for the treatment of periodontal disease in a periodontal orperiimplant tissue of a patient having periodontal disease comprising:A. a optical fiber extending between a proximal end and a distal end,the proximal end being adapted to receive optical energy incidentthereon in a near infrared spectral range, the optical fiber beingadapted to transmit the received optical energy to the distal end, andthe distal end being adapted to respond to the transmitted opticalenergy incident thereon, to emit, upon contact with at least a portionof the tissue, optical energy in a predetermined spectral range, whereinthe predetermined spectral range differs from the near infrared spectralrange; B. a reservoir adapted to store a chromophore dye, the dyecharacterized by an absorption spectrum in the predetermined spectralrange, the reservoir including an applicator assembly adapted to effectselective application of the chromophore dye to a region of the tissue.2. A kit according to claim 1, wherein the predetermined spectral rangeis from about 600 nm to about 700 nm.
 3. A kit according to claim 2,wherein the optical energy is at a wavelength of about 830 nm.
 4. A kitaccording to claim 1, further comprising an optical energy source forgenerating optical energy in the near infrared spectrum, and anassociated coupling assembly for coupling the optical energy to theproximal end of the optical fiber.
 5. The kit according to claim 4,wherein the predetermined spectral range is from about 600 nm to about700 nm.
 6. The kit according to claim 5, wherein the generated opticalenergy is coherent.
 7. The kit according to claim 6, wherein the opticalenergy source is a diode laser operating at about 500-1200 mW, forgenerating the optical energy at a wavelength of about 830 nm.
 8. Thekit according to claim 1, wherein the chromophore dye is selected fromthe group consisting of Methylene Blue, Toludine Blue, Congo Red, andMalachite Green, the dye being disposed in the reservoir.
 9. The kitaccording to claim 1, wherein the distal end of the optical fiber isfused silica.
 10. The kit according to claim 1, wherein lateral surfacesof the optical fiber extending from the distal end toward the proximalend, are adapted to cause optical radiation incident thereon andpropagating in the optical fiber from the distal end, to be refractedand pass through the lateral surfaces.
 11. A method for the treatment ofperiodontal disease in a periodontal or periimplant tissue of a patienthaving periodontal disease comprising the steps of: applying achromophore dye composition to the tissue, the dye compositioncomprising at least one dye that absorbs light energy comprising atleast one wavelength in a range of about 600 nm to 700 nm; andirradiating the periodontal or periimplant tissue with laser energycomprising at least one wavelength in a range from about 800 nm to about1064 nm emanating from an optical fiber.
 12. The method according toclaim 11, wherein the energy is coherent.
 13. The method according toclaim 11, wherein the laser energy is in the near infrared spectrum andis coherent.
 14. The method according to claim 11, wherein the laserenergy is generated by a diode laser operating at 500-1200 mW.
 15. Themethod according to claim 11, wherein the laser energy comprises awavelength of 830 nm.
 16. The method according to claim 11, wherein thedye composition is selected from the group consisting of Methylene Blue,Toludine Blue, Congo Red, and Malachite Green.
 17. The method accordingto claim 11, wherein the optical fiber is contacted with at least aportion of the tissue.
 18. The method according to claim 11, wherein thestep of irradiating the periodontal or periimplant tissue is for atherapeutically effective time in a moving pattern.
 19. The methodaccording to claim 11, wherein a solid coagulum is formed in proximityof the periodontal or periimplant tissue upon irradiating the tissuewith laser energy.
 20. The method according to claim 18, furtherincluding the step of mechanically removing the solid coagulum from thetissue by conventional periodontal scalers or ultrasonic scalers. 21.The method according to claim 17, further including the step ofadministering a therapeutically effective amount of an antibiotic to thepatient having periodontal disease.